Clinical Trials Logo

Birth Weight clinical trials

View clinical trials related to Birth Weight.

Filter by:
  • Enrolling by invitation  
  • Page 1

NCT ID: NCT05640297 Enrolling by invitation - Weight Gain Clinical Trials

"Impact of Kangaroo Mother Care Plus Massage Therapy on Growth of Preterm Low Birth Weight Infants at Discharge"

Start date: March 30, 2022
Phase: N/A
Study type: Interventional

Kangaroo mother care plus massage therapy will lead to improved growth of preterm low birth weight infants at discharge.

NCT ID: NCT05243537 Enrolling by invitation - Preterm Birth Clinical Trials

QTc Intervals in Former Preterm/Extreme Low Birth Weight Infants: a Pooled Study Proposal

Start date: January 1, 2023
Phase:
Study type: Observational

Pooling effort to collect previously reported data on QTc time in former preterm neonates, and compare these data to controls. At present and based on a recently conducted systematic search, there are conflicting data on the potential QT interval prolongation (all Bazett) in former extreme low birth weight (ELBW, <1000 g) infants or preterms. Consequently, if investigators truly want to assess the presence or absence of either a difference or a prolongation of QTc intervals in this specific population, pooling of published data is likely the most effective approach (potential number of cases = 24 + 49 + 93 = 166; potential number of controls in the same studies = 24 + 53 + 87 = 164), preferably based on individual data. Although the sample is to a large extent pragmatic (as available), the investigators hereby aim to target the 5 ms QTc prolongation applied by the authorities (FDA, EMA) in paired healthy adult volunteer studies as 'golden' standard as primary outcome variable [EMA guideline, FDA guidance].

NCT ID: NCT05166447 Enrolling by invitation - Obesity Clinical Trials

Twenty-year Follow-up of the Inter99 Cohort

Start date: September 13, 2021
Phase:
Study type: Observational

Being born small increases your risk of developing Type 2 diabetes (T2D) with age. Furthermore, data even suggest that some of the diseases ("complications") in the eyes, kidneys, nerves, liver, blood vessels and heart often seen in T2D patients may not only be due to high blood sugar levels, but rather they to some extent are due to reduced growth in your mother´s womb. The Inter99 cohort included 6784 Danish citizens aged 30 to 60 years when established 20 years ago. Data from the Inter99 cohort showed a strong role of low birth weight (LBW) on T2D risk. The aim is now to reexamine risk of T2D and complications in all the alive 6004 elderly Inter99 participants. Importantly, today there are available techniques to perform detailed examinations for even the earliest signs of complications in both subjects with and without diabetes, and the results of this study will altogether provide important new insights into both the origin and classification of T2D and associated complications. It is hypothesized that being born with lower birth weights increases the adult risk of T2D and heart disease and associated complications in the large and smaller blood vessels.

NCT ID: NCT03839173 Enrolling by invitation - Premature Infant Clinical Trials

Growth and Nutritional Status of Very Low Birth Weight Infants Fed a High Protein Exclusive Human Milk Diet

MedolacHMF
Start date: July 25, 2019
Phase: N/A
Study type: Interventional

The purpose of this two-arm investigation is to determine if growth patterns of very low birth weight infants (VLBW) (birth weight 750-1500 grams) fed human milk (maternal or donor) supplemented with a human milk-based fortifier grow according to established guidelines and maintain adequate micronutrient levels.

NCT ID: NCT03061968 Enrolling by invitation - Premature Clinical Trials

Study of Applying Acupressure in Low-birth Weight Premature

Start date: May 2010
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate the effects of acupressure application in very low birth weight premature.

NCT ID: NCT00964093 Enrolling by invitation - Clinical trials for Central Line Bloodstream Infections

The Effectiveness of Silver Alginate (Algidex) Patch in the Prevention of Central Line Infections in Very Low Birth Weight Infants

Start date: March 2009
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether silver alginate (Algidex) patch is effective in the prevention of central line infections in very low birth weight infants.